Closing a heart defect (PDA) with a catheter in children
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at how well children do when their PDA is closed using a catheter (a thin tube through a blood vessel). It helps doctors understand the best ways to treat this common heart condition in kids ages 6 months to 16 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has a Patent Ductus Arteriosus (PDA) – a small blood vessel near the heart that didn't close as it should after birth.
- This diagnosis must be confirmed by a heart ultrasound (echocardiogram).
- Your child must be between 6 months and 16 years old.
- Your child is scheduled to have the PDA closed using a thin tube (catheter) through a blood vessel, not open-heart surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how closing a heart valve problem (patent ductus arteriosus, or PDA) using a catheter procedure affects how your heart chambers change shape and work. Researchers want to understand if this minimally invasive procedure improves heart function.
This study keeps a national record of babies with a heart connection called a PDA who are being considered for closure using a catheter procedure. It may help doctors improve how they choose treatment and devices for babies with different health needs.
This trial compares an early procedure to close a heart vessel called the ductus arteriosus versus careful observation alone in very low-birth-weight preterm infants. It aims to see whether closing the vessel early can improve outcomes and be done safely.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
This study uses ultrasound to see if a heart blood vessel called the ductus arteriosus has closed after treatment in premature infants. It aims to find a better way to monitor the response to treatment without X-rays.
This trial monitors children who had a ventricular septal defect (VSD) closed with a device to see how they do over time. It checks if the closure stays effective and if there are any long-term issues.
Hear when a new Patent Ductus Arteriosus (PDA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.